Women's Health

Help Shape the Future of Denosumab Treatment

As biosimilars enter the denosumab landscape, your perspective as a healthcare provider is critical in understanding what factors influence treatment decisions. This brief survey explores your views on reimbursement considerations, coding challenges, switching comfort, and drivers of biosimilar choice. As a thank you, by completing the survey, you’ll be entered into a drawing for a chance to win a $200 gift card.

Take the survey now and make your voice heard

Latest News

Fewer Than 1 in 4 Women Maintain Optimal CV Health in Menopause: Daily Dose / image credit: ©New Africa/AdobeStock
Fewer Than 1 in 4 Women Maintain Optimal CV Health in Menopause: Daily Dose

August 20th 2025

Your daily dose of the clinical news you may have missed.

Investigational Psychedelic RE104 for Postpartum Depression Delivers Positive Phase 2 Results: Reunion Neuroscience Update / image credit UVA Health Anita Clayton, MD
Investigational Psychedelic RE104 for Postpartum Depression Delivers Positive Phase 2 Results: Reunion Neuroscience Update

August 18th 2025

Cardiovascular Health
Only 1 in 5 Women Meet Heart Health Targets at Midlife, and These 4 Factors Matter Most

August 4th 2025

New Guidelines Recommend Preconception Screening in Diabetes: Daily Dose / image credit: ©New Africa/AdobeStock
New Guidelines Recommend Preconception Screening in Diabetes: Daily Dose

August 4th 2025

Maternal Depression Found to Disrupt Emotional Responsiveness, Infant Care: Daily Dose / image credit: ©New Africa/AdobeStock
Maternal Depression Found to Disrupt Emotional Responsiveness, Infant Care: Daily Dose

July 31st 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.